Sfoglia per Autore
Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia
2011-04-01 Rufini, A; Fortuni, S; Arcuri, G; Condo', I; Serio, D; Incani, O; Malisan, F; Ventura, N; Testi, R
Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
2012-04-04 Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condo', I; Malisan, F; Al Mahdawi, S; Pook, M; Testi, R
Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans
2013-01-01 Schiavi, A; Torgovnick, A; Kell, A; Megalou, E; Castelein, N; Guccini, I; Marzocchella, L; Gelino, S; Hansen, M; Malisan, F; Condo', I; Bei, R; Rea, S; Braeckman, B; Tavernarakis, N; Testi, R; Ventura, N
Recovery of immunological homeostasis positively correlates both with early stages of right-colorectal cancer and laparoscopic surgery.
2013-09-09 Ferri, M; Rossi Del Monte, S; Salerno, G; Bocchetti, T; Angeletti, S; Malisan, F; Cardelli, P; Ziparo, V; Torrisi, M; Visco, V
Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
2014-12-01 Rufini, A; Cavallo, F; Condo', I; Fortuni, S; De Martino, G; Incani, O; DI VENERE, A; Benini, M; Massaro, D; Arcuri, G; Serio, D; Malisan, F; Testi, R
Src inhibitors modulate frataxin protein levels
2015-08-01 Cherubini, F; Serio, D; Guccini, I; Fortuni, S; Arcuri, G; Condo', I; Rufini, A; Moiz, S; Camerini, S; Crescenzi, M; Testi, R; Malisan, F
Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs)
2016-01-01 Leone, L; Raffa, S; Vetrano, M; Ranieri, D; Malisan, F; Scrofani, C; Vulpiani, Mc; Ferretti, A; Torrisi, Mr; Visco, V
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
2017-02-21 Benini, M; Fortuni, S; Condo', I; Alfedi, G; Malisan, F; Toschi, N; Serio, D; Massaro, D; Arcuri, G; Testi, R; Rufini, A
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia
2019-01-01 Alfedi, G; Luffarelli, R; Condo, I; Pedini, G; Mannucci, L; Massaro, Ds; Benini, M; Toschi, N; Alaimo, G; Panarello, L; Pacini, L; Fortuni, S; Serio, D; Malisan, F; Testi, R; Rufini, A
Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment
2019-07-01 Vetrano, M; Ranieri, D; Nanni, M; Pavan, A; Malisan, F; Vulpiani, Mc; Visco, V
Frataxin deficiency in Friedreich’s ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival
2020-01-01 Tiano, F; Amati, F; Cherubini, F; Morini, E; Vancheri, C; Maletta, S; Fortuni, S; Serio, D; Quatrana, A; Luffarelli, R; Benini, M; Alfedi, G; Panarello, L; Rufini, A; Toschi, N; Frontali, M; Romano, S; Marcotulli, C; Casali, C; Gioiosa, S; Mariotti, C; Mongelli, A; Fichera, M; Condò, I; Novelli, G; Testi, R; Malisan, F
Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1
2022-01-07 Quatrana, A; Morini, E; Tiano, F; Vancheri, C; Panarello, L; Romano, S; Marcotulli, C; Casali, C; Mariotti, C; Mongelli, A; Fichera, M; Rufini, A; Condò, I; Novelli, G; Testi, R; Amati, F; Malisan, F
Drug Repositioning in Friedreich Ataxia
2022-02-09 Rufini, A; Malisan, F; Condò, I; Testi, R
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-apr-2011 | Preventing the ubiquitin-proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia | Rufini, A; Fortuni, S; Arcuri, G; Condo', I; Serio, D; Incani, O; Malisan, F; Ventura, N; Testi, R | Articolo su rivista | |
| 4-apr-2012 | Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model | Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condo', I; Malisan, F; Al Mahdawi, S; Pook, M; Testi, R | Articolo su rivista | |
| 1-gen-2013 | Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans | Schiavi, A; Torgovnick, A; Kell, A; Megalou, E; Castelein, N; Guccini, I; Marzocchella, L; Gelino, S; Hansen, M; Malisan, F; Condo', I; Bei, R; Rea, S; Braeckman, B; Tavernarakis, N; Testi, R; Ventura, N | Articolo su rivista | |
| 9-set-2013 | Recovery of immunological homeostasis positively correlates both with early stages of right-colorectal cancer and laparoscopic surgery. | Ferri, M; Rossi Del Monte, S; Salerno, G; Bocchetti, T; Angeletti, S; Malisan, F; Cardelli, P; Ziparo, V; Torrisi, M; Visco, V | Articolo su rivista | |
| 1-dic-2014 | Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells | Rufini, A; Cavallo, F; Condo', I; Fortuni, S; De Martino, G; Incani, O; DI VENERE, A; Benini, M; Massaro, D; Arcuri, G; Serio, D; Malisan, F; Testi, R | Articolo su rivista | |
| 1-ago-2015 | Src inhibitors modulate frataxin protein levels | Cherubini, F; Serio, D; Guccini, I; Fortuni, S; Arcuri, G; Condo', I; Rufini, A; Moiz, S; Camerini, S; Crescenzi, M; Testi, R; Malisan, F | Articolo su rivista | |
| 1-gen-2016 | Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs) | Leone, L; Raffa, S; Vetrano, M; Ranieri, D; Malisan, F; Scrofani, C; Vulpiani, Mc; Ferretti, A; Torrisi, Mr; Visco, V | Articolo su rivista | |
| 21-feb-2017 | E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia | Benini, M; Fortuni, S; Condo', I; Alfedi, G; Malisan, F; Toschi, N; Serio, D; Massaro, D; Arcuri, G; Testi, R; Rufini, A | Articolo su rivista | |
| 1-gen-2019 | Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia | Alfedi, G; Luffarelli, R; Condo, I; Pedini, G; Mannucci, L; Massaro, Ds; Benini, M; Toschi, N; Alaimo, G; Panarello, L; Pacini, L; Fortuni, S; Serio, D; Malisan, F; Testi, R; Rufini, A | Articolo su rivista | |
| 1-lug-2019 | Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment | Vetrano, M; Ranieri, D; Nanni, M; Pavan, A; Malisan, F; Vulpiani, Mc; Visco, V | Articolo su rivista | |
| 1-gen-2020 | Frataxin deficiency in Friedreich’s ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival | Tiano, F; Amati, F; Cherubini, F; Morini, E; Vancheri, C; Maletta, S; Fortuni, S; Serio, D; Quatrana, A; Luffarelli, R; Benini, M; Alfedi, G; Panarello, L; Rufini, A; Toschi, N; Frontali, M; Romano, S; Marcotulli, C; Casali, C; Gioiosa, S; Mariotti, C; Mongelli, A; Fichera, M; Condò, I; Novelli, G; Testi, R; Malisan, F | Articolo su rivista | |
| 7-gen-2022 | Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1 | Quatrana, A; Morini, E; Tiano, F; Vancheri, C; Panarello, L; Romano, S; Marcotulli, C; Casali, C; Mariotti, C; Mongelli, A; Fichera, M; Rufini, A; Condò, I; Novelli, G; Testi, R; Amati, F; Malisan, F | Articolo su rivista | |
| 9-feb-2022 | Drug Repositioning in Friedreich Ataxia | Rufini, A; Malisan, F; Condò, I; Testi, R | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile